Search research articles
Contact Us
Filters
Showing results (131-140 of 169) with videos related to
Page
of 17
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 30, 2009
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease
John B Rose, Leslie Crews, Edward Rockenstein, et al.
Neurobiology of Disease
|
May 7, 2017
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
Omar El-Agnaf, Cassia Overk, Edward Rockenstein, et al.
Autophagy
|
June 1, 2012
Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway
Jochen Klucken, Anne-Maria Poehler, Darius Ebrahimi-Fakhari, et al.
Acta Neuropathologica Communications
|
January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
Brian Spencer, Elvira Valera, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 6, 2015
HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders
Jerel Fields, Wilmar Dumaop, Simona Eleuteri, et al.
Journal of Alzheimer'S Disease : JAD
|
August 24, 2011
Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice
Edward Rockenstein, Kiren Ubhi, Edith Doppler, et al.
Plos One
|
April 20, 2012
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy
Anna E Cartier, Kiren Ubhi, Brian Spencer, et al.
Plos One
|
November 25, 2010
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity
Diana L Price, Edward Rockenstein, Kiren Ubhi, et al.
Plos One
|
April 30, 2013
TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease
Andreas Bender, Paula Desplats, Brian Spencer, et al.
Plos One
|
September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases
Igor F Tsigelny, Leslie Crews, Paula Desplats, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 169) with videos related to
Sort By:
Page
of 17
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 30, 2009
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease
John B Rose, Leslie Crews, Edward Rockenstein, et al.
Neurobiology of Disease
|
May 7, 2017
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
Omar El-Agnaf, Cassia Overk, Edward Rockenstein, et al.
Autophagy
|
June 1, 2012
Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway
Jochen Klucken, Anne-Maria Poehler, Darius Ebrahimi-Fakhari, et al.
Acta Neuropathologica Communications
|
January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
Brian Spencer, Elvira Valera, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 6, 2015
HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders
Jerel Fields, Wilmar Dumaop, Simona Eleuteri, et al.
Journal of Alzheimer'S Disease : JAD
|
August 24, 2011
Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice
Edward Rockenstein, Kiren Ubhi, Edith Doppler, et al.
Plos One
|
April 20, 2012
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy
Anna E Cartier, Kiren Ubhi, Brian Spencer, et al.
Plos One
|
November 25, 2010
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity
Diana L Price, Edward Rockenstein, Kiren Ubhi, et al.
Plos One
|
April 30, 2013
TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease
Andreas Bender, Paula Desplats, Brian Spencer, et al.
Plos One
|
September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases
Igor F Tsigelny, Leslie Crews, Paula Desplats, et al.
Page
of 17